In-vitro Inflammatory Bowel Disease Diagnostic
Market
In-vitro Inflammatory Bowel Disease Diagnostic Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
In-vitro Inflammatory Bowel Disease Diagnostic Market Size and Growth
The In-vitro Inflammatory Bowel Disease Diagnostic market is experiencing significant growth due to rising IBD prevalence and advancements in diagnostic technologies. The market size is projected to reach approximately $3.5 billion by 2027, driven by increasing awareness, healthcare expenditure, and demand for precise diagnostic solutions tailored for IBD patients.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ DiaSorin S.p.A
◍ F. Hoffmann-La Roche Ltd
◍ Siemens Healthineers AG
◍ Abbott
◍ Quidel Corporation
The in-vitro inflammatory bowel disease diagnostic market is competitive, with key players including DiaSorin, Roche, Siemens Healthineers, Abbott, Quidel, ALPCO, Certest Biotec, and Biosystems. These companies innovate diagnostic solutions, enhancing accuracy and speed, thereby expanding market access.
Sales revenues (approximate):
- Abbott: $43 billion
◍ American Laboratory Products Company (ALPCO)
◍ Certest Biotec SL.
◍ Biosystems S.A.
- Roche: $63 billion
- Siemens Healthineers: $22 billion
Request Sample Report
Market Segmentation
By Application
Diagnostic Laboratories
Hospitals
◍ Research Institutes
Request Sample Report
By Product
Assays/Biomarker
Analyzers
Market Growth
Request Sample Report
$ X Billion USD
